Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.910

-0.3%

3:01 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (1774)	3/9/2008 8:38:58 PM
From: richardred	Read Replies (2) of 7240

SPPI-Have shares left. Replaced at years end 2007. Should have a good day Monday. FDA approval was a pleasant surprise. FDA Approves New Drug Application (NDA) for LEVOleucovorin>. Pfizer's recently been filling in a pipeline with some oncology products. With the new approval, 2.00 in cash and a present market cap of around 80 million. Just maybe somebody big, at the very least will want to partner. snip>Pfizer said it plans to expand its late-stage Phase III pipeline to 24 to 28 drug candidates by the end of next year, up from 16 now. The company said it will be creating a new business unit to look specifically at cancer, and devoted presentations to its portfolio of pain drugs and biotechnology products. online.wsj.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next